Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
An alternative to therapeutic targeting of oncogenes is to perform “synthetic lethality” screens for genes that are essential only in the context of specific cancer-causing mutations. We used high-throughput RNA interference (RNAi) to identify synthetic lethal interactions in cancer cells harboring...
Main Authors: | Scholl, Claudia, Frohling, Stefan, Dunn, Ian F., Schinzel, Anna C., Barbie, David A., Kim, So Young, Silver, Serena J., Tamayo, Pablo, Wadlow, Raymond C., Ramaswamy, Sridhar, Dohner, Konstanze, Bullinger, Lars, Sandy, Peter, Boehm, Jesse S., Root, David E., Hahn, William C., Gilliland, D. Gary, Jacks, Tyler E |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | en_US |
Published: |
Elsevier B.V.
2015
|
Online Access: | http://hdl.handle.net/1721.1/96267 https://orcid.org/0000-0001-5785-8911 |
Similar Items
-
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
by: Sandy, Peter, et al.
Published: (2014) -
STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability
by: Luo, Tuoping, et al.
Published: (2012) -
Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
by: Ling, Stephanie, et al.
Published: (2017) -
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
by: Shao, Diane D., et al.
Published: (2016) -
Identification of an oncogenic RAB protein
by: Wheeler, D. B., et al.
Published: (2017)